A series
of N2,N4-disubstituted
quinazoline-2,4-diamines has been synthesized
and tested against Leishmania donovani and L. amazonensis intracellular amastigotes. A structure–activity
and structure–property relationship study was conducted in
part using the Topliss operational scheme to identify new lead compounds.
This study led to the identification of quinazolines with EC50 values in the single digit micromolar or high nanomolar range in
addition to favorable physicochemical properties. Quinazoline 23 also displayed efficacy in a murine model of visceral leishmaniasis,
reducing liver parasitemia by 37% when given by the intraperitoneal
route at 15 mg kg–1 day–1 for
5 consecutive days. Their antileishmanial efficacy, ease of synthesis,
and favorable physicochemical properties make the N2,N4-disubstituted quinazoline-2,4-diamine
compound series a suitable platform for future development of antileishmanial
agents.